Vontobel Holding’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Buy
+4,000
New +$765K ﹤0.01% 864
2026
Q1
Sell
-4,000
Closed -$704K 1229
2025
Q4
$704K Buy
+4,000
New +$653K ﹤0.01% 875

Other funds holding BIIB

Vontobel Holding's BIIB Position: Q2 2026 in Review

Vontobel Holding increased its Biogen (BIIB) stake by 48% in Q2 2026, buying an estimated $1.26M and bringing the position to 20,311 shares worth $4.39M. The position accounts for 0.01% of the portfolio, ranked #474.

Vontobel Holding first reported a position in BIIB in Q4 2020 and has held it in 23 quarters since. The position peaked at $23.7M in Q4 2020. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Vontobel Holding held 20,311 shares of Biogen worth $4.39M as of Q2 2026.
  • Vontobel Holding bought 6,601 Biogen shares in Q2 2026, an estimated $1.26M.
  • Biogen made up 0.01% of Vontobel Holding's portfolio in Q2 2026, its #474 holding.
  • Vontobel Holding first reported a position in Biogen in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Biogen position peaked at $23.7M in Q4 2020.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.